Aldeyra Therapeutics, Inc. (ALDX)

Aldeyra Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	28.12	142.82	144.42	104.79	52.86	16.43
Short-Term Investments	44.62	-	29.88	-	-	28.94
Cash & Short-Term Investments	72.74	142.82	174.3	104.79	52.86	45.36
Cash Growth	-49.25%	-18.06%	66.33%	98.25%	16.52%	-8.54%
Other Receivables	-	-	3.24	0.03	-	-
Receivables	40	-	3.24	125.03	25	28
Prepaid Expenses	1.15	0.52	0.87	0.53	0.41	0.4
Other Current Assets	2.83	4.46	2.61	2.4	4.79	1.4
Total Current Assets	116.72	147.81	181.02	232.75	83.06	75.17
Property, Plant & Equipment	0.33	0.52	0.27	0.38	0.29	0.35
Long-Term Deferred Charges	0.27	-	-	-	-	-
Total Assets	117.32	148.33	181.29	233.14	83.35	75.52
Accounts Payable	0.19	1.34	0.13	1.02	0.38	0.81
Accrued Expenses	10.42	5.54	14.07	10.52	5.63	11.87
Current Portion of Long-Term Debt	0.28	15.15	0.91	-	3.66	-
Current Portion of Leases	0.26	0.24	0.25	0.23	0.23	0.23
Other Current Liabilities	-	-	-	-	2.5	-
Total Current Liabilities	17.15	22.26	15.36	11.77	12.41	12.91
Long-Term Debt	15	-	14.92	15.5	11.43	14.53
Long-Term Leases	0.07	0.27	-	0.13	-	-
Long-Term Unearned Revenue	-	6	-	-	-	-
Total Liabilities	32.22	28.53	30.28	27.4	23.84	27.44
Common Stock	0.06	0.06	0.06	0.06	0.04	0.03
Additional Paid-In Capital	519.27	513.99	507.77	500.37	296.39	247.41
Retained Earnings	-434.3	-394.26	-356.72	-294.69	-236.92	-199.36
Comprehensive Income & Other	0.07	-	-0.1	-	-	0.01
Total Common Equity	85.1	119.8	151.01	205.74	59.51	48.08
Shareholders' Equity	85.1	119.8	151.01	205.74	59.51	48.08
Total Liabilities & Equity	117.32	148.33	181.29	233.14	83.35	75.52
Total Debt	15.61	15.66	16.08	15.86	15.33	14.75
Net Cash (Debt)	57.13	127.17	158.22	88.93	37.53	30.61
Net Cash Growth	-55.07%	-19.63%	77.91%	136.96%	22.61%	-38.29%
Net Cash Per Share	0.96	2.16	2.71	1.65	1.10	1.13
Filing Date Shares Outstanding	59.55	58.9	58.58	58.1	47.25	29.66
Total Common Shares Outstanding	59.55	59.2	58.56	58.08	38.67	28.66
Working Capital	99.57	125.55	165.66	220.98	70.65	62.26
Book Value Per Share	1.43	2.02	2.58	3.54	1.54	1.68
Tangible Book Value	85.1	119.8	151.01	205.74	59.51	48.08
Tangible Book Value Per Share	1.43	2.02	2.58	3.54	1.54	1.68

Source: S&P Capital IQ. Standard template. Financial Sources.